Pharmacists in Pearl River, LA Accepting Medicare
3 Pharmacists found. Showing 1 - 3
 Katey James, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 61461 Highway 1090, Pearl River, LA 70452 Phone: 985-863-3737 |
 Mr. Clarence Clinton Miley Jr., RPH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 64288 Highway 41, Pearl River, LA 70452 Phone: 985-256-7222 Fax: 985-256-7224 |
Suhaskumar G Patel, R.PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 64060 Highway 41, Pearl River, LA 70452 Phone: 985-863-6444 |
News Archive
Standardized screening for early identification of delirium improves quality of care
A concerted effort to standardize delirium assessment and treatment helped a west Texas hospital reduce the use of high-risk medications and improve the quality of care for critically ill patients, according to a study published in Critical Care Nurse.
IMMY, University of Nevada, Reno collaborate to make new blood test for Cryptococcosis
A new, rapid blood test that could lead to early diagnosis and potentially save the lives of hundreds of thousands of people stricken with fungal meningitis, a leading cause of AIDS-related deaths in developing countries, is getting closer to market with a recent collaboration between the University of Nevada, Reno and Immuno-Mycologics in Oklahoma.
Study reveals link between genomic instability, aneuploidy and cancer
A recent analysis of 43,205 human tumours unveiled that 68% of solid tumours are aneuploid, that is to say, they have an altered number of chromosomes. In recent years, scientists have attempted to clarify whether this aneuploidy contributes to tumour development or whether it is a co-lateral effect of the genomic instability of cancer cells, which increase the rate of mutations and the likelihood of cancer.
NovaDigm Therapeutics initiates NDV-3A Phase 2a study for reduction of S. aureus in military trainees
NovaDigm Therapeutics, a company developing innovative immuno-therapeutics and preventative vaccines for fungal and bacterial infections, today announced the initiation of a Phase 2a study evaluating NDV-3A for the reduction of Staphylococcus aureus (S. aureus) colonization in a high-risk population of military trainees.
› Verified 1 days ago